Tagged with UAE,

UAE Amr Seif outlines Astellas’ progress into becoming a focused oncology speciality player in the Middle East and Africa, in line with the company’s global Corporate Strategic Plan 2021 (CSP2021). He also touches on key market trends in MEA, including regulatory developments, the rise of private insurance, and the growing importance…

UAE Tabuk Pharmaceuticals is a Saudi success story, now established as one of the GCC region’s leading private pharmaceutical companies. Gulf Manager Ossama Salah Ramadan explains what attracted him to the firm, his current strategic objectives in line with the company’s global growth goals, and some of the key local trends…

UAE 16-year Gilead veteran, Vítor Papão, recently left Europe to take on a new role within the company as general manager of the vast Middle East & Russia cluster. He discusses the particularities of the region, and the partnerships and initiatives Gilead is actively pursuing with local stakeholders.   We have…

UAE PhRMA MEA’s Samir Khalil highlights some of the key trends at play across the Middle East and Africa’s dynamic and fast-changing pharmaceutical ecosystem, including several wide-ranging national health transformation plans, the move towards health technology assessment (HTA), and the importance of maintaining robust intellectual property (IP) protection.   We can…

UAE Marwan Abdulaziz Janahi, Senior Vice President of Dubai Science Park, discusses the park’s key milestones and plans for the future, the positive changes in the UAE’s regulatory landscape since COVID, and his excitement about digital health trends and technologies.   At Dubai Science Park, we are proud to play a…

UAE AHK UAE CEO Oliver Oehms gives an overview of German healthcare investment in the Emirates, how the Chamber assists German firms in adjusting to the rapid pace of reform in the UAE, and his hopes for the future of German-Emirati economic cooperation more broadly.   We are confident that the…

UAE Dr Omar Hallak talks about the journey towards establishing a cardiovascular center of excellence at King’s College Hospital in the UAE and discusses advancements made in the field of cardiology in the country, particularly in terms of access to care, research, and technology.   With the advancements in technology and…

MEA Healthcare in the GCC continues to undergo major transformation with the introduction of government reforms, a shifting demographic and mandatory health insurance. These factors along with increased private sector participation and an ongoing infrastructure boom are poised to drive further growth in healthcare spending in the region – up to…

MENA Amira Younes of AbbVie UAE examines how the COVID-19 pandemic highlighted the need for new ways of thinking about delivering regulatory effectiveness and efficiency in the region, and for flexibility from all stakeholders to ensure that therapies continue to reach patients in a timely manner.   Most countries in the…

UAE As a part of its continued digitalisation efforts, the United Arab Emirates (UAE) has launched the region’s first pharmaceutical track-and-trace system, Tatmeen. With the new system, which will monitor each stage of drug production, the country aims to boost transparency, eliminate the sale of counterfeit medicines, build trust in the…

UAE A roundup of the latest pharma news from the United Arab Emirates (UAE) including Julpher’s pursuit of its growth strategy with a new CEO, Global Pharma’s tech transfer deal with Egypt’s Nerhado and Pharma Solutions’ procurement of its first thalassemia generic.   AstraZeneca announces move to Dubai Science Park with…

Middle East & Africa The Middle East and Africa (MEA), the fifth-largest regional pharma market in the world, is rapidly becoming a pharmaceutical powerhouse with both global and local firms taking advantage of the region’s population and life expectancy growth as well as greater government funding for healthcare and the progress of universal healthcare…